| 1 |
10010568 |
AG-370
|
|
|
- IC50 = 20 μM in human bone marrow fibroblasts
- IC50 = 820 μM
|
ag-370
|
| 2 |
10010311 |
AG-490
|
|
|
- 5 μM blocks growth of pre-B acute leukemia (ALL) cells
|
ag-490
|
| 3 |
10010242 |
AG-494
|
|
|
- IC50 = 1 μM in HT- 22 cells
|
ag-494
|
| 4 |
10010243 |
AG-825
|
|
|
- IC50 = 0.35 µM
- IC50 = 19 µM
- IC50 = 40 µM
|
ag-825
|
| 5 |
10010242 |
AG-494
|
|
|
- IC50 = 1 µM in HT-22 cells
|
ag-494
|
| 6 |
10010243 |
AG-825
|
|
|
- IC50 = 0.35 μM
- IC50 = 19 μM
- IC50 = 40 μM
|
ag-825
|
| 7 |
10005167 |
Genistein
|
|
|
- Tyrosine-phosphorylation of histone H2B
|
genistein
|
| 8 |
13166 |
Gefitinib
|
|
|
- IC50 = 0.2 nM-0.4 μM in various cancer cell lines
|
gefitinib
|
| 9 |
10008131 |
JNJ-10198409
|
|
|
|
jnj-10198409
|
| 10 |
10010265 |
LFM-A13
|
|
|
|
lfm-a13
|
| 11 |
10010265 |
LFM-A13
|
|
|
|
lfm-a13
|
| 12 |
10010422 |
Nilotinib
|
|
|
- IC50 = 15 nM in wild-type Bcr/Abl
|
nilotinib
|
| 13 |
10010309 |
RG-13022
|
|
|
- IC50 = 1 µM in HT-22 cells
|
rg-13022
|
| 14 |
10010310 |
RG-14620
|
|
|
- IC50 = 3 µM in HT-22 cells
|
rg-14620
|
| 15 |
10010248 |
AG-17
|
|
|
- IC50 = 460 µM in human epidermoid carcinoma A431 cells
|
ag-17
|
| 16 |
10010300 |
AG-18
|
|
|
- IC50 = 35 µM in human epidermoid carcinoma A431 cells
|
ag-18
|
| 17 |
10010312 |
AG-82
|
|
|
- IC50 = 3 µM in human epidermoid carcinoma A431 cells
|
ag-82
|
| 18 |
10010313 |
AG-99
|
|
|
- IC50 = 10 µM in human epidermoid carcinoma A431 cells
|
ag-99
|
| 19 |
10010314 |
AG-213
|
|
|
- IC50 = 2.4 µM in human epidermoid carcinoma A431 cells
|
ag-213
|
| 20 |
10010315 |
AG-183
|
|
|
- IC50 = 0.8 µM in human epidermoid carcinoma A431 cells
|
ag-183
|
| 21 |
10010592 |
AG-1296
|
|
|
- IC50 = 0.4 μM (both in vitro and in Swiss 3T3 cells)
|
ag-1296
|
| 22 |
10010238 |
Erbstatin Analog
|
|
|
|
erbstatin-analog
|
| 23 |
10010329 |
Lavendustin C
|
|
|
|
lavendustin-c
|
| 24 |
10010568 |
AG-370
|
|
|
- IC50 = 20 μM
- IC50 = 820 μM
|
ag-370
|